ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Ophthalmology

Top Ophthalmology Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH PHAM MD

Ophthalmology

6,250

$462K

871
801 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 57%

$74
Average prescription price

Avg: $67

STEVEN DAY M.D.

Ophthalmology

4,952

$337K

732
676 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 57%

$68
Average prescription price

Avg: $67

ANNISA JAMIL M.D.

Ophthalmology

4,564

$346K

599
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 57%

$76
Average prescription price

Avg: $67

TUONG NGUYEN M.D.

Ophthalmology

4,454

$393K

626
591 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 57%

$88
Average prescription price

Avg: $67

BARBARA SMIT M.D.

Ophthalmology

3,671

$151K

641
596 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 57%

$41
Average prescription price

Avg: $67

RODGER BODOIA MD

Ophthalmology

3,509

$221K

571
502 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 57%

$63
Average prescription price

Avg: $67

MICHAEL FIELD MD

Ophthalmology

3,207

$186K

581
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 57%

$58
Average prescription price

Avg: $67

HOWARD BARNEBEY M.D.

Ophthalmology

3,134

$405K

545
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

84%
prescriptions for brand name drugs

Avg: 57%

$129
Average prescription price

Avg: $67

RICHARD MILLS M.D.

Ophthalmology

3,021

$197K

443
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 57%

$65
Average prescription price

Avg: $67

ABEL LI M.D.

Ophthalmology

2,989

$186K

657
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 57%

$62
Average prescription price

Avg: $67

JOHN WHITEHEAD M.D.

Ophthalmology

2,875

$180K

502
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 57%

$63
Average prescription price

Avg: $67

PARAG GOKHALE MD

Ophthalmology

2,700

$182K

387
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 57%

$67
Average prescription price

Avg: $67

GARY CHUNG M.D.

Ophthalmology

2,538

$218K

568
525 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 57%

$86
Average prescription price

Avg: $67

ADAM BRAGANZA MD

Ophthalmology

2,535

$97.4K

529
510 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 57%

$38
Average prescription price

Avg: $67

BRUCE CAMERON MD

Ophthalmology

2,494

$162K

462
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 57%

$65
Average prescription price

Avg: $67

BRANT CARROLL M.D.

Ophthalmology

2,456

$117K

514
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 57%

$48
Average prescription price

Avg: $67

PHILIP CHEN M.D.

Ophthalmology

2,382

$112K

282
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 57%

$47
Average prescription price

Avg: $67

DENISE DUDLEY M.D.

Ophthalmology

2,338

$195K

453
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 57%

$83
Average prescription price

Avg: $67

DELFRED DIEHL M.D., FRCSC

Ophthalmology

2,297

$103K

415
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 57%

$45
Average prescription price

Avg: $67

BRIAN LUETH M.D.

Ophthalmology

2,292

$148K

500
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 57%

$64
Average prescription price

Avg: $67

FIONA DURCAN M.D.

Ophthalmology

2,261

$143K

322
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 57%

$63
Average prescription price

Avg: $67

MARK SOONTORNVACHRIN

Ophthalmology

2,240

$96.4K

531
515 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 57%

$43
Average prescription price

Avg: $67

STEPHEN RECK MD

Ophthalmology

2,179

$116K

362
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 57%

$53
Average prescription price

Avg: $67

MARK TAYLOR MD

Ophthalmology

2,168

$123K

485
458 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 57%

$57
Average prescription price

Avg: $67

SILVIO GURDIAN MD

Ophthalmology

2,163

$171K

397
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 57%

$79
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank